| Name | E104 |
|---|
| Description | E104 (compound 1) is a potent and selective TLR7 agonist. E104 can be delivered by antibody-drug conjugate (ADC) technology to elicit potent anticancer activity. E104 induces the activation of mouse macrophages and hPBMCs[1]. |
|---|---|
| Related Catalog | |
| Target |
TLR7 |
| References |
| Molecular Formula | C21H23N5 |
|---|---|
| Molecular Weight | 345.44 |